Instadose Pharma Company Insiders

Instadose Pharma Management Team Effectiveness

The company has return on total asset (ROA) of (694.0616) % which means that it has lost $694.0616 on every $100 spent on assets. This is way below average. Instadose Pharma's management efficiency ratios could be used to measure how well Instadose Pharma manages its routine affairs as well as how well it operates its assets and liabilities. At present, Instadose Pharma's Return On Equity is projected to increase slightly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 623.27, whereas Net Tangible Assets are projected to grow to (138.8 K). As of March 23, 2025, Common Stock Shares Outstanding is expected to decline to about 82.5 M. The current year's Net Loss is expected to grow to about (395 K)

Instadose Pharma Workforce Comparison

Instadose Pharma Corp Benchmark Summation

Instadose Pharma Notable Stakeholders

The success or failure of an entity such as Instadose Pharma Corp often depends on how effective the management is. Instadose Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Instadose management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Instadose management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Instadose Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Instadose Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Instadose Pharma's management manipulating its earnings.

When running Instadose Pharma's price analysis, check to measure Instadose Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Instadose Pharma is operating at the current time. Most of Instadose Pharma's value examination focuses on studying past and present price action to predict the probability of Instadose Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Instadose Pharma's price. Additionally, you may evaluate how the addition of Instadose Pharma to your portfolios can decrease your overall portfolio volatility.